Skip to main content
Anthony Cleare

Professor Anthony Cleare

Professor of Psychopharmacology & Affective Disorders

Research interests

  • Psychiatry

Biography

Anthony Cleare BSc MBBS PhD FRCPsych is a Professor of Psychopharmacology & Affective Disorders at the Institute of Psychiatry, Psychology & Neuroscience at King's College London. 

Professor Cleare trained in psychiatry at the Bethlem Royal and Maudsley hospitals in London, also spending time as a liaison psychiatrist at King’s College Hospital. At the end of his training, he was awarded the Laughlin Prize of the Royal College of Psychiatrists for the highest examination performance nationally. 

In 1998, he obtained his PhD looking at neuroendocrine aspects of affective disorders and has since continued an active research programme into all aspects of affective disorders.  

Professor Cleare is consultant psychiatrist in The National Affective Disorders Service at the Maudsley Hospital, offering a tertiary care service specialising in the multidisciplinary assessment and treatment of patients with treatment resistant depression and bipolar disorder. 

He is also specialist advisor in aviation psychiatry to the Civil Aviation Authority. He has previously worked as a psychiatrist in several medical clinics including a pain clinic, a chronic fatigue syndrome clinic and a general medical outpatient clinic. 

Professor Cleare has over 380 peer-reviewed and other publications and has contributed to many books and national guidelines, most recently the British Association for Psychopharmacology Evidence-Based Guidelines for Treating Depressive Disorders. 

Research Interests

  • Clinical psychopharmacology; neuroendocrinology and neurochemistry and functional neuroimaging (PET and f-MRI) of depression,  
  • chronic fatigue syndrome and aggression;  
  • neuroimaging of serotonin receptor function;  
  • biological effects of psychological therapies  

Expertise and Public Engagement

Professor Cleare is Treasurer of the International Society for Affective Disorders and a member of many scientific societies including the British Association for Psychopharmacology. 

    Research

    brain trees
    Centre for Affective Disorders

    The Centre for Affective Disorders focuses on mood and anxiety disorders, common disorders which cause great suffering for many people.

    MNT logo
    Maudsley Neurotechnology (MNT)

    Maudsley Neurotechnology is a clinical and academic centre for evaluating and delivering evidence-based neurotechnology treatments for mental health disorders

    Affective Disorders
    Affective Disorders Research Group

    The Affective Disorders Research Group works to understand more about the neurobiological causes of mood disorders (also known as affective disorders).

    News

    Quetiapine augmentation found to be more clinically and cost-effective for treatment-resistant depression compared to lithium

    New research has found that quetiapine augmentation – a treatment for depression in people that have't fully responded to antidepressants – is both more...

    Packet of pills

    Features

    Maudsley Debates - 51st to 60th

    The Maudsley Debates take place three times a year at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN). Topics generally focus on issues that...

    Maudsley Debates 3 1800x500

      Research

      brain trees
      Centre for Affective Disorders

      The Centre for Affective Disorders focuses on mood and anxiety disorders, common disorders which cause great suffering for many people.

      MNT logo
      Maudsley Neurotechnology (MNT)

      Maudsley Neurotechnology is a clinical and academic centre for evaluating and delivering evidence-based neurotechnology treatments for mental health disorders

      Affective Disorders
      Affective Disorders Research Group

      The Affective Disorders Research Group works to understand more about the neurobiological causes of mood disorders (also known as affective disorders).

      News

      Quetiapine augmentation found to be more clinically and cost-effective for treatment-resistant depression compared to lithium

      New research has found that quetiapine augmentation – a treatment for depression in people that have't fully responded to antidepressants – is both more...

      Packet of pills

      Features

      Maudsley Debates - 51st to 60th

      The Maudsley Debates take place three times a year at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN). Topics generally focus on issues that...

      Maudsley Debates 3 1800x500